Enseval Putera Megatrading Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enseval Putera Megatrading Tbk PT with three other
drug stores in Asia:
Shandong Realcan Pharmaceutical Co Ltd
sales of 7.79 billion Chinese Renmimbi [US$1.22 billion]
of which 100%
was Medical Devices Sales),
Cachet Pharmaceutical Company., Limited
(5.57 billion Chinese Renmimbi [US$876.22 million]
of which 99%
was Commerce), and
Hokuyaku Takeyama Holdings, Inc
based in Japan
(214.47 billion Japanese Yen [US$1.79 billion]
of which 74%
was Pharmaceutical Business).
Enseval Putera Megatrading Tbk PT reported sales of 17.01 trillion Indonesian Rupiahs (US$1.16 billion)
December of 2014.
increase of 8.9%
versus 2013, when the company's sales were 15.62 trillion Indonesian Rupiahs.
Sales at Enseval Putera Megatrading Tbk PT have increased during each of the previous five years
(and since 2009, sales have increased a total of 99%).
Sales of Consumer Products saw an increase
13.1% in 2014, from
6.66 trillion Indonesian Rupiahs to 7.53 trillion Indonesian Rupiahs.
Not all segments of Enseval Putera Megatrading Tbk PT experienced an increase in sales in 2014:
sales of Other fell 5.2% to 2.12 trillion Indonesian Rupiahs.